Outbreak of infections by hepatitis B virus genotype A and transmission of genetic drug resistance in patients coinfected with HIV-1 in Japan

Journal of Clinical Microbiology

Volumn 49, Issue 3, 2011, Pages 1017-1024

  Fujisaki, Seiichiro ^a   Yokomaku, Yoshiyuki ^a   Shiino, Teiichiro ^b   Koibuchi, Tomohiko ^c   Hattori, Junko ^a   Ibe, Shiro ^a   Iwatani, Yasumasa ^a,d   Iwamoto, Aikichi ^c   Shirasaka, Takuma ^e   Hamaguchi, Motohiro ^f   Sugiura, Wataru ^a,d  

^a NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e OSAKA NATIONAL HOSPITAL   (Japan)

^f SUWA RED CROSS HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; EMTRICITABINE; ENTECAVIR; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; TENOFOVIR;

ADULT; ANTIVIRAL RESISTANCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDEMIC; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION RATE; INFECTION RISK; JAPAN; MALE; MALE HOMOSEXUAL; MIXED INFECTION; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; UNINDEXED SEQUENCE; VIRUS TRANSMISSION;

ADULT; ANTIVIRAL AGENTS; CLUSTER ANALYSIS; DISEASE OUTBREAKS; DNA, VIRAL; DRUG RESISTANCE, VIRAL; FEMALE; GENETIC VARIATION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HIV INFECTIONS; HIV-1; HUMANS; JAPAN; MALE; MIDDLE AGED; PHYLOGENY; SEQUENCE ANALYSIS, DNA;

HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79952323182     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02149-10     Document Type: Article

References (36)

1. Allen, M. I., et al. 1998. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology 27:1670-1677. (Pubitemid 28264693)
2. Angus, P., et al. 2003. Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase. Gastroenterology 125:292-297. (Pubitemid 36929407)
3. Drummond, A. J., S. Y. Ho, M. J. Phillips, and A. Rambaut. 2006. Relaxed phylogenetics and dating with confidence. PLoS Biol. 4:e88.
4. Drummond, A. J., and A. Rambaut. 2007. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol. Biol. 7:214.
5. Gatanaga, H., et al. 2007. Drug-resistant HIV-1 prevalence in patients newly diagnosed with HIV/AIDS in Japan. Antiviral Res. 75:75-82. (Pubitemid 46610525)
6. Harrigan, P. R., S. Bloor, and B. A. Larder. 1998. Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitro. J. Virol. 72:3773-3778.
7. Johnson, V. A., et al. 2009. Update of the drug resistance mutations in HIV-1: December 2009. Top. HIV Med. 17:138-145.
8. Koibuchi, T., et al. 2001. Predominance of genotype A HBV in an HBV-HIV- 1 dually positive population compared with an HIV-1-negative counterpart in Japan. J. Med. Virol. 64:435-440.
9. Matsuura, K., et al. 2009. Distribution of hepatitis B virus genotypes among patients with chronic infection in Japan shifting toward an increase of genotype A. J. Clin. Microbiol. 47:1476-1483.
10. Michitaka, K., et al. 2006. Tracing the history of hepatitis B virus genotype D in western Japan. J. Med. Virol. 78:44-52.
11. Miyakawa, Y., and M. Mizokami. 2003. Classifying hepatitis B virus genotypes. Intervirology 46:329-338. (Pubitemid 38037030)
12. Norder, H., et al. 2004. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47:289-309. (Pubitemid 39541275)
13. Noto, H., et al. 2003. Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus carrier state in Shizuoka, Japan during 1980-1994. J. Gastroenterol. Hepatol. 18:943-949. (Pubitemid 37056174)
14. Nylander, J. 2004. MrModeltest v2. Uppsala University, Uppsala, Sweden.
15. Oda, T. 2000. Further decline of hepatitis B surface antigen (HBsAg) prevalence in Japan. Jpn. J. Cancer Res. 91:361.
16. Okada, K., I. Kamiyama, M. Inomata, M. Imai, and Y. Miyakawa. 1976. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N. Engl. J. Med. 294:746-749.
17. Orito, E., et al. 2001. Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology 34:590-594. (Pubitemid 32786652)
18. Osiowy, C., E. Giles, Y. Tanaka, M. Mizokami, and G. Y. Minuk. 2006. Molecular evolution of hepatitis B virus over 25 years. J. Virol. 80:10307-10314.
19. Pybus, O. G., A. J. Drummond, T. Nakano, B. H. Robertson, and A. Rambaut. 2003. The epidemiology and iatrogenic transmission of hepatitis C virus in Egypt: a Bayesian coalescent approach. Mol. Biol. Evol. 20:381-387.
20. Quarleri, J., et al. 2007. Hepatitis B virus genotype distribution and its lamivudine-resistant mutants in HIV-coinfected patients with chronic and occult hepatitis B. AIDS Res. Hum. Retroviruses 23:525-531.
21. Rambout, A., and A. J. Drummond. 2007. Tracer v1.4. Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, Scotland. http://tree.bio.ed.ac.uk.
22. Schaefer, S. 2007. Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J. Gastroenterol. 13:14-21.
23. Shafer, R. 2010, posting date. Stanford drug resistance database. http://hivdb.stanford.edu/.
24. Sheldon, J., et al. 2005. Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir. Antivir. Ther. 10:727-734.
25. Shiraki, K. 2000. Perinatal transmission of hepatitis B virus and its prevention. J. Gastroenterol. Hepatol. 15(Suppl.):E11-E15.
26. Soriano, V., et al. 2010. Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe. J. Antimicrob. Chemother. 65:548-555.
27. Sugauchi, F., et al. 2001. A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness. J. Gen. Virol. 82:883-892.
28. Suzuki, Y., et al. 2005. Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan. J. Med. Virol. 76:33-39.
29. Swafford, D. 2003. PAUP. Phylogenetic analysis using parsimony (and other methods), version 4. Sinouer Associates, Sunderland, MA.
30. Takeda, Y., et al. 2006. Difference of HBV genotype distribution between acute hepatitis and chronic hepatitis in Japan. Infection 34:201-207. (Pubitemid 44214504)
31. Tanaka, J., et al. 2004. Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995-2000. Intervirology 47:32-40.
32. Tenney, D. J., et al. 2004. Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to lamivudine. Antimicrob. Agents Chemother. 48:3498-3507.
33. Trimoulet, P., et al. 2007. Hepatitis B virus genotypes: a retrospective survey in southwestern France, 1999-2004. Gastroenterol. Clin. Biol. 31:1088-1094.
34. Westland, C. E., et al. 2003. Week 48 resistance surveillance in two phase 3 clinical studies of adefovir dipivoxil for chronic hepatitis B. Hepatology 38:96-103. (Pubitemid 36775800)
35. Yang, H., et al. 2002. Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeks. Hepatology 36:464-473. (Pubitemid 34810368)
36. Yotsuyanagi, H., et al. 2005. Distinct geographic distributions of hepatitis B virus genotypes in patients with acute infection in Japan. J. Med. Virol. 77:39-46.